Document Detail


Modification of the core lipids of low density lipoproteins produces selective alterations in the expression of apoB-100 epitopes.
MedLine Citation:
PMID:  1693649     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The conformation of the apolipoprotein B-100 associated with low density lipoproteins (LDL) is not fixed. Rather, the conformations of several regions are subject to alteration by a variety of metabolic and therapeutic perturbations that change either the lipid compositions and/or sizes of LDL particles. However, because these perturbations simultaneously alter several structural-compositional features of the particles it has been difficult to relate structural-compositional features of LDL to apoB-100 conformations. Furthermore, in in vivo studies several days pass between samplings, thus different sets of particles are studied before and after experimental perturbation. In the present experiments more discrete perturbations of LDL were obtained in vitro by incubating LDL with very low density lipoproteins (VLDL) in the presence of partially purified human plasma lipid transfer proteins. The conformations of apoB on the LDL particles then were examined a) by probing epitope expression and b) by examining interactions between LDL and LDL-receptors in cultured human fibroblasts. During incubations with VLDL and lipid transfer proteins, the diameters of LDL particles decreased; the percentage composition of LDL triglycerides increased three-to fivefold; concomitantly, cholesteryl esters decreased. Lipid transfer protein was required for the transfer to occur and the magnitude of the increase in LDL-triglycerides depended upon the duration of incubation, the ratio of VLDL/LDL, and unknown properties specific to the various LDL preparations. The fact that the triglyceride contents of all LDL preparations were not identically affected suggests that initial packaging of the core region may affect capacity for lipid exchange.(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
M Kinoshita; E S Krul; G Schonfeld
Related Documents :
15146369 - Qualitative effect of fenofibrate and quantitative effect of atorvastatin on ldl profil...
8489129 - Hypo- and hyperresponse of serum cholesterol level and low density lipoprotein producti...
19852889 - Nutritional supplements and serum lipids: does anything work?
22062949 - Omega-3 fatty acids enhance mitochondrial superoxide dismutase activity in rat organs d...
241519 - Zonal ultracentrifugation of plasma lipoproteins from normal and cholestatic pigs.
21700429 - The relationship of ketosis and growth to the efficacy of the ketogenic diet in infanti...
20675109 - Early development of essential fatty acid deficiency in rats: fat-free vs. hydrogenated...
3244049 - Morphological evaluation of the atherogenicity of corn oil, hydrogenated corn oil, and ...
8399089 - Dietary n-3 polyunsaturated fatty acids prevent the development of atherosclerotic lesi...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of lipid research     Volume:  31     ISSN:  0022-2275     ISO Abbreviation:  J. Lipid Res.     Publication Date:  1990 Apr 
Date Detail:
Created Date:  1990-07-16     Completed Date:  1990-07-16     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0376606     Medline TA:  J Lipid Res     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  701-8     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO 63110.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Apolipoprotein B-100
Apolipoproteins B / immunology*
Binding, Competitive
Carrier Proteins / metabolism
Enzyme-Linked Immunosorbent Assay
Epitopes*
Humans
Lipoproteins, LDL / analysis,  metabolism*
Lipoproteins, VLDL / metabolism
Protein Conformation
Receptors, LDL / metabolism
Time Factors
Triglycerides / analysis,  metabolism
Grant Support
ID/Acronym/Agency:
HL15308/HL/NHLBI NIH HHS; HL42460/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Apolipoprotein B-100; 0/Apolipoproteins B; 0/Carrier Proteins; 0/Epitopes; 0/Lipoproteins, LDL; 0/Lipoproteins, VLDL; 0/Receptors, LDL; 0/Triglycerides; 0/lipid transfer protein; 0/low density lipoprotein triglyceride

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Morphological and quantitative aspects of the development of cytoplasmic granules in concanavalin A-...
Next Document:  Influence of zygapophyseal joint orientation on hyaline cartilage at the thoracolumbar junction.